002332 Stock Overview
Manufactures and sells steroids and hormones worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 5/6 |
My Notes
Capture your thoughts, links and company narrative
Zhejiang Xianju Pharmaceutical Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥10.28 |
| 52 Week High | CN¥14.80 |
| 52 Week Low | CN¥8.44 |
| Beta | -0.19 |
| 1 Month Change | -14.76% |
| 3 Month Change | -13.97% |
| 1 Year Change | -18.54% |
| 3 Year Change | -16.63% |
| 5 Year Change | 4.15% |
| Change since IPO | 15.48% |
Recent News & Updates
There's No Escaping Zhejiang Xianju Pharmaceutical Co.,Ltd.'s (SZSE:002332) Muted Earnings
Dec 10
Zhejiang Xianju PharmaceuticalLtd (SZSE:002332) Seems To Use Debt Quite Sensibly
Oct 16A Look At The Intrinsic Value Of Zhejiang Xianju Pharmaceutical Co.,Ltd. (SZSE:002332)
Sep 03Recent updates
There's No Escaping Zhejiang Xianju Pharmaceutical Co.,Ltd.'s (SZSE:002332) Muted Earnings
Dec 10Zhejiang Xianju PharmaceuticalLtd (SZSE:002332) Seems To Use Debt Quite Sensibly
Oct 16A Look At The Intrinsic Value Of Zhejiang Xianju Pharmaceutical Co.,Ltd. (SZSE:002332)
Sep 03Zhejiang Xianju PharmaceuticalLtd (SZSE:002332) Will Pay A Dividend Of CN¥0.30
Jun 02Estimating The Fair Value Of Zhejiang Xianju Pharmaceutical Co.,Ltd. (SZSE:002332)
Apr 15There Is A Reason Zhejiang Xianju Pharmaceutical Co.,Ltd.'s (SZSE:002332) Price Is Undemanding
Mar 05Shareholder Returns
| 002332 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -3.3% | -1.0% | 0.4% |
| 1Y | -18.5% | -3.0% | 12.3% |
Return vs Industry: 002332 underperformed the CN Pharmaceuticals industry which returned -3% over the past year.
Return vs Market: 002332 underperformed the CN Market which returned 12.3% over the past year.
Price Volatility
| 002332 volatility | |
|---|---|
| 002332 Average Weekly Movement | 5.4% |
| Pharmaceuticals Industry Average Movement | 7.4% |
| Market Average Movement | 8.8% |
| 10% most volatile stocks in CN Market | 13.0% |
| 10% least volatile stocks in CN Market | 5.8% |
Stable Share Price: 002332 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 002332's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1972 | 3,281 | Weihua Jin | www.xjpharma.com |
Zhejiang Xianju Pharmaceutical Co.,Ltd. manufactures and sells steroids and hormones worldwide. The company offers gynecological, anesthesia, respiratory, dermatology, generic drug, and other products; and active pharmaceutical ingredients (API), such as corticosteroids, sex hormone, progesterone, non-hormone series, newchem API, and intermediates products.
Zhejiang Xianju Pharmaceutical Co.,Ltd. Fundamentals Summary
| 002332 fundamental statistics | |
|---|---|
| Market cap | CN¥10.17b |
| Earnings (TTM) | CN¥621.66m |
| Revenue (TTM) | CN¥4.12b |
16.4x
P/E Ratio2.5x
P/S RatioIs 002332 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 002332 income statement (TTM) | |
|---|---|
| Revenue | CN¥4.12b |
| Cost of Revenue | CN¥1.86b |
| Gross Profit | CN¥2.26b |
| Other Expenses | CN¥1.64b |
| Earnings | CN¥621.66m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.63 |
| Gross Margin | 54.84% |
| Net Profit Margin | 15.08% |
| Debt/Equity Ratio | 1.7% |
How did 002332 perform over the long term?
See historical performance and comparisonDividends
2.9%
Current Dividend Yield48%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/25 17:41 |
| End of Day Share Price | 2024/12/25 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Zhejiang Xianju Pharmaceutical Co.,Ltd. is covered by 15 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yue Gao | Changjiang Securities Co. LTD. |
| Pei Cheng | China Galaxy Securities Co., Ltd. |
| Feifei Xu | China Merchants Securities Co. Ltd. |